Also trades as: ROIVW (NASDAQ) · $vol 0M
ROIV Smart Money
Roivant Sciences Ltd.
1W: +4.6%
1M: -1.2%
3M: +11.2%
YTD: +66.6%
1Y: +100.5%
3Y: +278.3%
5Y: +482.8%
$36.54
+0.49 (+1.36%)
Weekly Expected Move ±5.5%
$32
$34
$36
$39
$41
Credit Risk of going bust: lower than 90% of companies Debt: 0.4% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.01 (down more than 99.9%), Roivant Sciences Ltd. would be worth roughly what it owes.
Total debt $107.2M against a stock market value of $26.39B.
Distance to default 13.63 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $53.6M (short-term plus half of long-term), stock volatility 45.2%; Altman Z'' 16.14. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $107.2M against a stock market value of $26.39B.
Distance to default 13.63 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $53.6M (short-term plus half of long-term), stock volatility 45.2%; Altman Z'' 16.14. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026542
Institutions Holding
+49 vs prior
74.4%
Ownership
+19.67%
100
New
201
Increased
183
Reduced
41
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-23 | MOMTAZEE JAMES C | director | F-Tax Withholding | 77 | $36.49 | $3K | Filing |
| 2026-10-23 | MOMTAZEE JAMES C | director | A-Grant/Award | 383 | $— | $0 | Filing |
| 2026-10-23 | Epperly Melissa B, | director | F-Tax Withholding | 116 | $36.49 | $4K | Filing |
| 2026-10-23 | Epperly Melissa B, | director | A-Grant/Award | 513 | $— | $0 | Filing |
| 2026-10-23 | Oren Ilan | director | A-Grant/Award | 810 | $— | $0 | Filing |
| 2026-10-20 | Venker Eric | officer: president & immunovant ceo | S-Sale | 14,144 | $35.42 | $501K | Filing |
| 2026-10-20 | Venker Eric | officer: president & immunovant ceo | S-Sale | 185,856 | $35.09 | $6.5M | Filing |
| 2026-10-16 | Gline Matthew | officer: ceo | F-Tax Withholding | 34,638 | $33.53 | $1.2M | Filing |
| 2026-10-16 | Sukhatme Mayukh | officer: president & cio | F-Tax Withholding | 19,976 | $33.53 | $670K | Filing |
| 2026-10-01 | Epperly Melissa B, | director | S-Sale | 900 | $36.57 | $33K | Filing |
| 2026-10-01 | Epperly Melissa B, | director | S-Sale | 16,850 | $36.08 | $608K | Filing |
| 2026-09-30 | Gline Matthew | officer: ceo | F-Tax Withholding | 76,171 | $36.57 | $2.8M | Filing |
| 2026-09-30 | Venker Eric | officer: president & immunovant ceo | S-Sale | 200,000 | $36.62 | $7.3M | Filing |
| 2026-09-30 | Torti Frank | officer: president and vant chair | F-Tax Withholding | 40,309 | $36.57 | $1.5M | Filing |
| 2026-09-30 | Sukhatme Mayukh | officer: president & cio | F-Tax Withholding | 46,879 | $36.57 | $1.7M | Filing |
| 2026-09-20 | Humes Jennifer | officer: chief accounting officer | F-Tax Withholding | 3,880 | $39.77 | $154K | Filing |
| 2026-09-20 | Pulik Richard | officer: cfo | F-Tax Withholding | 2,129 | $39.77 | $85K | Filing |
| 2026-09-16 | MANCHESTER KEITH S | director | A-Grant/Award | 5,054 | $— | $0 | Filing |
| 2026-09-16 | Epperly Melissa B, | director | A-Grant/Award | 5,054 | $— | $0 | Filing |
| 2026-09-16 | Fitzgerald Meghan | director | A-Grant/Award | 5,054 | $— | $0 | Filing |
| 2026-09-16 | MOMTAZEE JAMES C | director | A-Grant/Award | 5,054 | $— | $0 | Filing |
| 2026-09-16 | Oren Ilan | director | A-Grant/Award | 5,054 | $— | $0 | Filing |
| 2026-09-16 | Gold Daniel Allen | director | A-Grant/Award | 5,054 | $— | $0 | Filing |
| 2026-09-15 | Fitzgerald Meghan | director | S-Sale | 400 | $40.45 | $16K | Filing |
| 2026-09-15 | Epperly Melissa B, | director | S-Sale | 4,338 | $39.65 | $172K | Filing |
🏛️ Congressional Trades
7 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2025-10-31 | Lisa C. McClain | House | Sell | $1,001 - $15,000 | Filing |
| 2025-10-30 | Lisa C. McClain | House | Sell | $1,001 - $15,000 | Filing |
| 2025-10-30 | Lisa C. McClain | House | Buy | $1,001 - $15,000 | Filing |
| 2025-10-29 | Lisa C. McClain | House | Buy | $1,001 - $15,000 | Filing |
| 2025-10-29 | Lisa C. McClain | House | Sell | $1,001 - $15,000 | Filing |
| 2025-06-17 | Lisa McClain | House | Buy | $1,001 - $15,000 | Filing |
| 2025-06-16 | Lisa C. McClain | House | Buy | $1,001 - $15,000 | Filing |
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| FMR LLC | 81,020,390 | $2.9B | +3,039,137 | 2026-06-30 | Filing |
| BlackRock, Inc. | 48,236,091 | $1.7B | +3,981,831 | 2026-06-30 | Filing |
| MORGAN STANLEY | 42,592,905 | $1.5B | -9,235,420 | 2026-06-30 | Filing |
| QVT Financial LP | 23,723,074 | $840M | -1,438,163 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 22,123,198 | $783M | +1,442,626 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 21,641,339 | $766M | +1,802,641 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 18,556,458 | $657M | +7,444,867 | 2026-06-30 | Filing |
| STATE STREET CORP | 17,795,975 | $630M | +1,609,362 | 2026-06-30 | Filing |
| UBS Group AG | 17,466,641 | $618M | -5,152,831 | 2026-06-30 | Filing |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 14,309,000 | $506M | +4,634,000 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 11,674,380 | $426M | +1,491,903 | 2026-06-30 | Filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 10,349,328 | $366M | -2,444,769 | 2026-06-30 | Filing |
| Two Seas Capital LP | 8,475,356 | $300M | -852,935 | 2026-06-30 | Filing |
| Assenagon Asset Management S.A. | 8,362,952 | $296M | +1,286,464 | 2026-06-30 | Filing |
| PERCEPTIVE ADVISORS LLC | 8,085,461 | $286M | -200,000 | 2026-06-30 | Filing |
| Patient Square Capital LP | 8,020,928 | $284M | -145,119 | 2026-06-30 | Filing |
| Invesco Ltd. | 7,531,192 | $267M | +1,092,047 | 2026-06-30 | Filing |
| Darwin Global Management, Ltd. | 6,747,300 | $234M | -50,000 | 2026-06-30 | Filing |
| AQR CAPITAL MANAGEMENT LLC | 6,633,560 | $234M | +686,702 | 2026-06-30 | Filing |
| VIKING GLOBAL INVESTORS LP | 6,271,467 | $222M | -380,981 | 2026-06-30 | Filing |